Clinical trial
XVIVO Heart Perfusion System (XHPS) With Supplemented XVIVO Heart Solution (SXHS)
NCT05881278
Study timeline
Study start (actual)2023-10-10Date precision: day
Registry last updated2026-08-17
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Heart Failureunresolved
Transplant; Failure, Heartunresolved
Interventions
Sponsors & collaborators
XVIVO Perfusionlead sponsor
Mapped research locations
New YorkNew York, United States2Los AngelesCalifornia, United States2BaltimoreMaryland, United States2ChicagoIllinois, United States1DallasTexas, United States1St LouisMissouri, United States1AtlantaGeorgia, United States1NashvilleTennessee, United States1SeattleWashington, United States1ClevelandOhio, United States1PittsburghPennsylvania, United States1ColumbusOhio, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT05881278 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.